Poland Contraceptive Devices Market Report 2022 to 2030

Poland Contraceptive Devices Market Analysis

$ 3999

Poland's Contraceptive Devices Market is expected to witness growth from $75 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.45% for the forecasted year 2022-30. In Poland, the demand for contraceptive devices is rising as consumers become more aware of the advantages of family planning and contraception. The market is segmented by type and by gender. Some key players in this market include Polfa Tarchomin, Biovico, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10PLMD005 CATEGORY: Medical Devices GEOGRAPHY: Poland AUTHOR: Jigyasu Bhandari

Buy Now

Poland Contraceptive Devices Healthcare Market Executive Analysis

Poland's Contraceptive Devices Market is expected to witness growth from $75 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.45% for the forecasted year 2022-30. In the European Union (EU), Poland has among the lowest health spending. Health expenditures in 2015 were $1347.23 per capita, or 6.3% of GDP, compared to the average for the EU, which was $2975.89, or 9.9% of GDP. Less than the EU average of 79%, 72% of expenses are paid for using public money. The somewhat significant out-of-pocket spending (22%) raises questions regarding accessibility. Despite falling from 28% in 2001 to 23% in 2014, Poland still has a higher rate of daily smokers among adults than the majority of other European Union (EU) nations.

In Poland, there were 3 maternal deaths for every 100,000 live births in 2022. This indicates that maternal health outcomes in Poland are generally good because the rate is quite low when compared to many other nations. In Poland, 22,000 chlamydia infections were reported in 2022, with a prevalence rate of 57.7 cases per 100,000 people. This shows that chlamydia is a widespread STI in Poland since the incidence rates are comparable to those reported in other European nations. Other STIs, such as gonorrhea and syphilis, had lower incidence rates; in Poland in 2022, there were about 3,500 instances of gonorrhea and 500 cases of syphilis, respectively.

In Poland, contraceptive methods are used to prevent unintended pregnancies and encourage family planning. When used appropriately and regularly, contraceptive methods are quite successful at preventing pregnancy. They provide a dependable way of birth control and can assist single people and married couples in organising and spacing out their pregnancies. Compared to traditional birth control measures like condoms or oral contraceptives, contraceptive devices are frequently more convenient to use. Contraceptive implants or intrauterine devices can be implanted only once to offer long-term protection without the requirement for daily or weekly upkeep. Many contraceptive methods are economical in the long run since they offer protection for a number of years without requiring continuous costs like condoms or oral contraceptives.

Poland Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Poland, the demand for contraceptive devices is rising as consumers become more aware of the advantages of family planning and contraception. Additionally, the use of contraception is becoming more widely accepted as a standard component of family planning and reproductive health. The demand for barrier methods of contraception like condoms is rising in Poland as a result of the rising prevalence of STIs. This is anticipated to increase the nation's contraceptive devices market. The demand for more expensive and sophisticated contraceptive methods, like hormonal IUDs and contraceptive patches, is anticipated to increase in Poland as disposable income and healthcare spending rise.

Market Restraints

Poland is a conservative nation with strong religious and cultural beliefs, which might make it difficult for some forms of contraception, such as hormonal methods, to be used or accepted. This may reduce the market for these goods and make it difficult for producers to sell them here. Despite government initiatives to support family planning, Poland still has some areas with poor access to healthcare, especially in rural areas. This may reduce the need for and availability of contraceptive methods. Although Poland is becoming more aware of contraception, many people are still uninformed about the various kinds of contraceptive methods that are available. This can limit demand for these products and make it difficult for manufacturers to market them effectively.

Competitive Landscape

Key Players

Polfa Tarchomin (PL)
Biovico (PL)
Mylan Laboratories
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

In Poland, manufacturers of contraceptive devices must register their products with the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products (URPL) in order to advertise and sell their products. The registration procedure can be difficult and drawn out, but if it is finished, the product can be advertised and sold all across the nation. Although the government does offer subsidies for some products, the prices of contraceptive methods are typically set by the makers themselves in Poland. The National Health Fund will also pay for some contraceptive products, albeit the reimbursement amounts will vary based on the product and its category.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.